This study differentiates myeloproliferative syndromes based on 195 cases. Key distinctions involve secondary, idiopathic, and malignant neoplastic myeloproliferation, aiding in accurate diagnosis and understanding disease progression.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: